Although the discovery of bioluminescence dates back to the 1500s, it wasn’t until 1852 that the term “fluorescence” came into use. “Fluorescence” was coined by George Gabriel Stokes (Web ref:1, Kalyuzhny 2016) after discovering that the mineral fluorite emitted visible light after exposure to ultraviolet light. A century later, in 1955, Green Fluorescent protein (GFP) was isolated from the Jellyfish Aequorea victoria by Davenport & Nichol (2). However, it wasn’t until 1996, when Roger Tsien’s group identified a point mutation in GFP (S65T), making the protein practical for research applications, that GFP’s research possibilities were realized (3).
Since then, with optimization, the recombinant protein GFP has been modified to yield many variations in color, from cyan and the original green through to the reds of mCherry and mTomato, with improvements in photostability, brightness, and experimental vigor.
GFP provided a starting block for the study of biological processes in living cells and the development of techniques that wouldn’t be possible without the unique properties of color. The impact of GFP on the world of research was highlighted by the award of the Nobel Prize for Chemistry in 2008 to Shimomura, Tsien, and Chalfie for their work on GFP (3).
GFP and its analogs can be “coded” into the protein sequence and “expressed” as part of the protein at points deemed appropriate based on structure and known or predicted function. Expression of GFP fusion proteins can present challenges that can limit their use. Although they may enable experiments such as co-localization or even Förster Resonance Energy Transfer (FRET), allowing stoichiometrical characterization, such experiments require careful development.
Figure 1: The crystal structure of GFP (A + B) shows how the beta-barrel protects the chromophore (C) within. (PDB code 1EMA) (5)
Transfection of plasmids coding for the fluorescent protein and the gene of interest can be time-consuming, requiring optimization, and the fluorophore may change the behavior of the protein of interest, negating the value of the experiment.
Fluorescence, however, was a captivating characteristic that, if harnessed, the potential value of which scientists couldn’t ignore. This led researchers to develop other methods to add fluorophores to their molecules of interest without the artifacts incurred by expressing a recombinant fluorescent protein.
The antigen:antibody interaction is a tractable way of labeling proteins in situ on live cells, as well as adding multiple fluorescent molecules per antigen–amplifying signal. Fluorescent molecules suitable for labeling have been developed from the phycobiliproteins of photosynthetic algae (8) to the much smaller organic dyes like Alexa Fluor® and Cyanine dyes, and much smaller fluorescent particles like Quantum dots. These other molecules have increased the range of colors available to scientists and have enhanced the qualities of the fluorophores available, allowing their application to be diversified into numerous techniques.
Organic dyes and fluorescent proteins can be used as fluorescent probes conjugated (or “tagged”) to antibodies, allowing the researcher to take advantage of many of the benefits of in situ staining over recombinant expression of fluorophores.
The first conjugated fluorophores to appear were FITC (fluorescein isothiocyanate) and TRITC (tetramethyl rhodamine isothiocyanate) (7) back in the 1950s. As computing power has increased to cope with the processing demands of multi-channel experiments and our optical techniques have developed, the range of available dyes has exploded.
Figure 2: Alexa Fluor® 488 and 594 dye molecules (6).
Conjugated fluorescent probes offer numerous advantages to recombinant proteins. They can have less potential for steric interference and expression artifacts, as well as offer the signal enhancement benefits of indirect detection – by binding more dye molecules per antigen molecule – potentially increasing the brightness – adding sensitivity to the assay. The antibody conjugates can also offer improved photostability, decreased photobleaching, and a more “user-friendly” format. Numerous fluorescent conjugates are available, spanning the spectrum from blue through to infrared.
Jackson ImmunoResearch offers a comprehensive collection of conjugates spanning the entire spectrum. Phycobiliproteins – Phycoerythrin (PE), Peridinin chlorophyll protein (PerCP), and Allophycocyanin (APC), Alexa Fluor®, Brilliant Violet, and Cyanine dyes conjugated to Jackson Immunoresearch’s secondary antibodies offer a kaleidoscope of possibility.